Show simple item record

The effects of sunitinib malate used in targeted therapy on the proliferation of HeLa cells in vitro

dc.contributor.authorTekisogullari, K.
dc.contributor.authorTopcul, MEHMET RIFKI
dc.date.accessioned2021-03-05T17:15:58Z
dc.date.available2021-03-05T17:15:58Z
dc.date.issued2013
dc.identifier.citationTekisogullari K., Topcul M. R. , "The effects of sunitinib malate used in targeted therapy on the proliferation of HeLa cells in vitro", JOURNAL OF BUON, cilt.18, ss.253-260, 2013
dc.identifier.issn1107-0625
dc.identifier.othervv_1032021
dc.identifier.otherav_c4adbe35-14cd-45f6-80b0-eeeb5dba6d72
dc.identifier.urihttp://hdl.handle.net/20.500.12627/130443
dc.description.abstractPurpose: In this study, the antiproliferative and apoptotic effects of sunitinib (SU-11248, Sutent) which is used for targeted therapy was evaluated on HeLa cell line originated from human cervix carcinoma.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleThe effects of sunitinib malate used in targeted therapy on the proliferation of HeLa cells in vitro
dc.typeMakale
dc.relation.journalJOURNAL OF BUON
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume18
dc.identifier.issue1
dc.identifier.startpage253
dc.identifier.endpage260
dc.contributor.firstauthorID59621


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record